Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
GIVLAARI® (givosiran injection) Now Widely Reimbursed in Canada For the Treatment of Acute Hepatic Porphyria (AHP) in Adults [Yahoo! Finance]
High Growth Tech Stocks To Watch For Future Potential [Yahoo! Finance]
Exploring Three High Growth Tech Stocks For Potential Portfolio Enhancement [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.